AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
03 juin 2024 08h14 HE
|
AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush
27 mai 2024 03h01 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
Global Cephalosporin Drug Market Report 2024 Insights and Forecasts 2019-2022 and 2023-2029 - The Role of Advanced Cephalosporin Formulations, New Generations and Combination Therapies in Development
22 févr. 2024 06h16 HE
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Cephalosporin Drug Market (2024 Edition): Analysis by Generation, Route of Administration, Application (Respiratory Tract Infection, Skin...
Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen & Technology 2023-2027, with Profiles of 30 Companies Including Accelerate Diagnostics, Binx Health, GeneFluidics & OpGen
16 févr. 2024 04h08 HE
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027"...
Antimicrobial Resistance Surveillance Market: Projected Growth at 5.6% CAGR Through 2028
23 janv. 2024 06h13 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public...
LifeArc - New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance
30 nov. 2023 02h00 HE
|
LifeArc
New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance The second round of the Diagnostics for One Health and User Driven Solutions...
Global Carbapenem Market Research Report 2023-2030: Meropenem Dominates the Market Due to Broad-Spectrum Activity
27 nov. 2023 05h28 HE
|
Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Carbapenem Market Size, Share & Trends Analysis Report By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (UTI, Blood Stream...
Er-Kim Pharmaceuticals Supports Worldwide Prevention of Antimicrobial Resistance (AMR)
24 nov. 2023 08h00 HE
|
Er-Kim Pharmaceuticals
Er-Kim Pharmaceuticals joins the industry to collaborate on the prevention of antimicrobial resistance (AMR) in support of World AMR Awareness Week
Global Antibiotic Resistance Markets, 2023-2027: Beyond Antibiotics - Exploring Cutting-Edge Trends in AMR Solutions
05 oct. 2023 06h43 HE
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Tinea Pedis Treatment Market Poised for Expansion: Opportunities in Rising Fungal Infections 2023 to 2030
29 sept. 2023 07h23 HE
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Tinea Pedis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's...